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was observed when embryonic kidneys, harvested at day-13 ofIdentification of up-regulated Ras-like GTPase, Rap1b, by sup-
gestation, were exposed to high glucose ambience.pression subtractive hybridization.
Conclusion. The data suggest that Rap1b, a GTP-bindingBackground. Diabetic nephropathy accounts for over 30%
protein that plays a critical role in various signaling intracellularof the end-stage renal disease (ESRD). A number of defined
events, is another molecule that may be relevant to the pathobi-mechanisms and molecules that are involved in its pathogenesis
ology of diabetic nephropathy.are known, while others remain to be identified.
Methods. Suppression subtraction hybridization (SSH)-poly-
merase chain reaction (PCR) was employed to search for new
genes that may be relevant to the pathogenesis of diabetic
Diabetic nephropathy, a common complication of dia-nephropathy during embryonic development, the time when
betes mellitus, is a leading cause of end-stage renal dis-the kidney is most susceptible to various forms of stress. A
diabetic state was induced in pregnant mice at day-13 of ges- ease in the United States [1], and approximately 40% of
tation by administration of streptozotocin. The kidneys of patients with insulin-dependent diabetes mellitus (IDDM)
newborn mice with blood glucose level 200 mg/dL were har- develop diabetic nephropathy during the course of theirvested, mRNA isolated and subjected to SSH-PCR. Several
disease and progress to chronic renal failure [2–5]. Be-differentially expressed cDNA fragments with up-regulated ex-
sides nephropathy and other well-known complicationspression were isolated. One of the cDNA fragments had homol-
ogy with human Ras-like guanine 5-triphosphate (GTPase), of diabetes that are seen in adult life, diabetes also can
Rap1b gene. By utilizing the ZAP II mouse cDNA library and adversely influence growth of the mammalian embryo.
SMARTRACE amplification, a full-length Rap1b cDNA was Such a complication that occurs in a hyperglycemic envi-isolated. A recombinant protein was generated in pET15b bac-
ronment during gestation has been ascribed as diabeticterial expression system. An anti-Rap1b antibody was raised
embryopathy [6]. Diabetic embryopathy is seen in 2 to 3%in rabbits by immunizing them with the fusion protein, and its
specificity was confirmed by Western blot analysis. of the offspring of juvenile mothers with uncontrolled
Results. Rap1b cDNA had an open reading frame of 552 diabetes mellitus. It affects a number of organ systems,
bp with a predicted putative protein size of 21 kD. In vitro including central nervous system, cardiovascular, gastro-translation verified the authentication of the Rap1b cDNA
intestinal, urogenital and lumbosacral-musculoskeletalclone. Northern blot analyses revealed a single2.3 kb Rap1b
systems. The latter abnormality is known as “caudal re-mRNA transcript. Its expression was up-regulated in several
tissues, including the kidney of newborn diabetic mice. The gression syndrome,” which is sometimes associated with
degree of up-regulation of Rap1b mRNA expression was pro- urogenital anomalies, such as, partial or complete agene-
portional to the blood glucose levels. Western blot analyses sis of kidneys and ureters. With respect to the urogenitalconfirmed the hyperglycemia-induced up-regulation of the
anomalies, there are few reports in the literature thatRap1b expression. In situ hybridization and immunofluores-
describe the dysmorphogenesis of the embryonic kidneycence studies revealed that Rap1b was expressed in the inner
medullary collecting tubules. During hyperglycemia, its expres- in a high glucose ambience [7, 8]. These reports describe
sion was accentuated and extended into the outer medullary a relationship between glucose-induced dysmorphogene-
and cortical collecting tubules. Similar up-regulation of Rap1b sis with adenosine 5-triphosphate (ATP)-depletion or its
intracellular redistribution, accentuated apoptosis and per-
turbed epithelial-mesenchymal interactions that are me-Key words: GTP binding protein, diabetic nephropathy, renal develop-
ment, Rap1b, neonate, end-stage renal disease. diated by various extracellular matrix (ECM) morphoge-
netic molecules, such as, sulfated proteoglycans [7, 8].Received for publication May 17, 2001
There are a diverse group of molecules that regulateand in revised form July 17, 2001
Accepted for publication July 19, 2001 morphogenesis of the kidney, including growth factors
and their receptors, ECM proteins and their receptors, 2001 by the International Society of Nephrology
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that is, integrins and matrix degrading enzymes, proto- a blood glucose monitor (Boehringer Mannheim Inc.,
Mannheim, Germany), and the female mice with bloodonocogenes and transcription factors [9, 10]. The status
of some of the macromolecules, such as ECM proteins, glucose levels 250 mg/dL were selected for continua-
tion of their pregnancy. The newborn mice of controlhas been studied during glucose-induced dysmorphogen-
esis of the kidney [7, 8, 11], while the pathogenetic role of non-diabetic and diabetic mothers were weighed and
blood glucose levels determined immediately after birth,others remains to be investigated. Lately, a tremendous
interest has arisen in intracellular signaling molecules, and their kidneys harvested, snap-frozen in liquid nitro-
gen and processed for various studies.for example, protein kinase C, Smad proteins, mitogen-
activated protein kinases, arachidonic acid metabolites
PCR-select cDNA subtractionand reactive oxygen species [12–16]. The functions of
these molecules are entwined, and they affect the activi- Total RNA was extracted from newborn kidneys by acid
guanidinium isothiocyanate-phenol-chloroform extractionties of other macromolecules that are implicated in the
pathogenesis of diabetic complications. In view of the method [20]. RNA was digested with RNase-free DNase
(1 U/mL) in the presence of ribonuclease inhibitor (1current interest in the signaling molecules and gaps in
our knowledge of the pathogenesis of hyperglycemia- U/L) for 60 minutes at 37C. Another chloroform-phe-
nol extraction was performed, and the RNA was repre-induced renal complications in the developing kidney,
studies were initiated to search for molecules that have cipitated with ethanol in the presence of RNase-free glyco-
gen as a carrier (1 g/L). Poly(A) RNA was purifiedaberrant expression and may be relevant in the develop-
ment of such complications. This was achieved by em- by employing a Oligotex mRNA mini kit (Qiagen Co.,
Hilden, Germany) and used for cDNA synthesis. First-ploying one of the subtractive hybridization techniques,
known as suppression subtractive hybridization. During strand cDNA was synthesized by using 20 units of Super-
Script II RNase H reverse transcriptase (GIBCO BRL(SSH)-polymerase chain reaction (PCR), the normal
population of mRNAs is subtracted from the mRNAs Co., Grand Island, NY, USA) in a total volume of 10
L of the reaction mixture containing 2 g of Poly(A)isolated from the newborn mice kidney following a hy-
perglycemic stress, and then the differentially expressed RNA, 10 mol/L of 3 random hexamer primer (GIBCO
BRL), 1 L of deoxynucleoside triphosphate (dNTP)genes can be isolated and characterized. This technique
seems to have certain advantages over other subtraction mix (10 mmol/L each), 2 L of 5  reverse transcriptase
buffer (250 mmol/L Tris-HCl, pH 8.5, 150 mmol/L KCl,methods in that it is relatively less time consuming, re-
quires a small amount of mRNA (0.5 to 2 g) and it 40 mmol/L MgCl2 and 5 mmol/L dithiothreitol (DTT)
at 42C for 11⁄2 hours. The second strand cDNA synthesis,readily identifies low abundance mRNA transcripts that
are differentially expressed in response to a given stimu- Rsa I endonuclease enzyme digestion, adapter ligation,
hybridization and polymerase chain reaction (PCR) am-lus [17–19]. Another advantage of using this PCR-based
method is that one can identify differentially expressed plification were preformed as described in cDNA sub-
traction kit manual (Clontech Co., Palo Alto, CA, USA).genes before the development of any phenotype, and this
becomes highly relevant in the pathobiology of diabetes Certain modifications were made, and they were as fol-
lows: (1) A fourfold greater than recommended amountsince the end organ damage is a relatively late complica-
tion in humans or in other experimental models. Our of driver cDNA during the second hybridization was used.
(2) Kidney mRNA of animals with glucose level 250study describes the identification of a signaling molecule
that may be relevant to the pathobiology of the kidney mg/dL was employed as the “tester” and control as the
“driver.” (3) Primary amplification included 30 PCR cy-during development.
cles and the secondary included 18 cycles. The PCR prod-
ucts were analyzed and by 1.5% agarose gel electropho-
METHODS
resis, using 100-bp ladder DNA as the markers. The
Animals and induction of diabetes differential PCR products in “tester” cDNA population
subtracted from the “driver” were gel-purified and clonedThree-month-old ICR mice (Harlan Co., Indianapolis,
IN, USA) were housed in the animal facilities, and fed into plasmid vector pCR2.1 (InVitrogen Co., San Diego,
CA, USA). The products were sequenced and subjectedstandard laboratory chow (62% carbohydrate, 26% pro-
tein, and 12% fat in caloric percentage). Paired male: to homology search by using BLAST program at the web
site of National Center of Biotechnology Informationfemale mating was carried out, and the day of mating was
designated as day-0 of gestation. On day-13 of gestation, (http://www.ncbi.nlm.nih.gov/BLAST/).
diabetes was induced by an intraperitoneal injection of
Northern analysesstreptozotocin (STZ; 200 mg/kg of body weight; Sigma
Chemical Co., St. Louis, MO, USA) in a citrate buffer To confirm the expression status of the genes isolated by
suppression-subtractive hybridization–PCR (SSH-PCR),at pH 4.6. Control mice received citrate buffer only. At
day-16 of gestation, blood glucose was measured, using Northern blot analyses were performed as previously
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described [21]. Briefly, the total RNA was isolated from clones were sequenced to ensure the fidelity of Taq poly-
merase. An online homology search was performed usingkidneys of diabetic and control newborn mice and poly
(A) RNA purified as described above. Two micrograms the BLAST program.
of poly(A) RNA were subjected to 1.5% agarose gel
In vitro translation studieselectrophoresis containing 2.2 mol/L formaldehyde and
capillary-transferred to the Hybond N nylon membranes To confirm the open reading frame (ORF) of the mouse
Rap1B cDNA clones and to verify the size of putative(Amersham Co., Arlington Heights, IL, USA). After
ultraviolet (UV) cross-linking the RNA to the mem- protein product, in vitro translation was preformed. Two
Rap1b full-length cDNAs were selected as the template.branes (UV Stratalinker 2400, Stratagene Co., La Jolla,
CA, USA), prehybridization was carried out at 65C for A PCR product of 557 bp using sense (5-GCATCATG
CGTGAGTACAAGCTA-3) and antisense (5-TTAAfour hours in a solution containing 5  standard sodium
citrate (SSC), 5  Denhardt’s solution, 0.5% sodium AGCAGCTGACACGATGAC-3) primers was gener-
ated, and it was subcloned into pCR II vector (InVitro-dodecyl sulfate (SDS) and 100 g/mL herring sperm
DNA. The membranes were then hybridized with vari- gen Co.) and sequenced. The plasmid vector was linear-
ized at the 3 noncoding region by digestion with Xho I.ous [32P]dCTP-labeled (1  106 cpm/mL) partial-length
cDNA fragments, derived from SSH-PCR, at 65C for A TNT-coupled reticulocyte lysate in vitro translation sys-
tem was used (Promega Co., Madison, WI, USA). The18 hours. The membranes also were hybridized with radio-
labeled 	-actin cDNA. The blots were washed under high translation was carried out in a total volume of 25 L,
containing 12.5 L of rabbit reticulocyte lysate, 1 L orstringency conditions and autoradiograms prepared.
The Rap1B mRNA expression in newborn kidneys of reaction buffer, 7.5 U of T7 RNA polymerase, 1 mmol/L
amino acid mixture, 1 L of [35S]methionine (10 mCi/mice with different glucose levels also was evaluated by
Northern blot analyses. In addition, mRNA expression mL) and 20 U of RNase inhibitor. The reaction products
were subjected to 10% SDS-polyacrylamide gel electro-in different tissues (kidney, liver, brain, lung and heart)
of newborn diabetic mice was assessed. The [32P]dCTP- phoresis (PAGE) and autoradiograms prepared [24]. A
positive control included luciferase-encoding plasmidlabeled Rap1b cDNA, generated by PCR using the prim-
ers shown in Figure 3A, was used as a hybridization probe. that yields a translated product of 61 kD.
Generation and characterization of recombinantIsolation of a full-length mouse Rap1b cDNA
fusion protein, and antibody productionInitially, phage DNA was prepared from mouse kid-
ney ZAP cDNA library that is available in our labora- Two expression constructs were generated by PCR us-
ing full-length Rap1B cDNAs isolated above as template.tory [22, 23]. The DNA was used as a template for the
isolation of Rap1B cDNA by PCR using T7 as sense A Nde I (CATATG) and BamH I (GGATCC) sites were
introduced using sense (5-GGGGGCATATGATGCprimer (5-TAATACGACTCACTATAGGG-3) and
mouse Rap1B sequence, derived from SSH-PCR cDNA GTGAGTACAAGCT-3) and antisense (5-GGGG
GGGATCCTGAAGCAGCTGACACGATGACT-3)fragment (vide supra), as antisense primer (5-TTAAA
GCAGCTGACACGATGAC-3). PCR was performed primers. Flanking GC clamps (GGGGGG) were also
included in the primer sequences. The PCR productsin a volume of 50 L containing PCR buffer (10 mmol/L
Tris-HCl, pH 8.3, 50 mmol/L KCl and 1.5 mmol/L were digested with Nde I and BamH I, gel purified and
ligated into Nde I and BamH I-digested pET15b plasmidMgCl2), 200 mol/L dNTPs, 2.5 units of Taq polymerase
(Perkin Elmer Co., Norwalk, CT, USA) and 10 mol/L vector (Novagen). The constructs (pET15b/Rap1b) were
sequenced to ensure proper in-frame ligation, Taq poly-of primers. Amplification was carried out as follows: 94C
for three minutes, 58C for two minutes, and 72C for merase fidelity and their 5 and 3 end orientation. The
transformation was performed by using bacterial hostone minute (1 cycle); and 94C for one minute, 58C for
one minute, and 72C for one minute (32 cycles). To BL21(DE3) (Novagen). A single colony was picked, and
the bacteria were allowed to grow in LB medium untilamplify the Rap1b 5- and 3-flanking regions, SMART
RACE cDNA amplification protocol was employed (Clon- an A600 of 0.6 was achieved. Expression of fusion proteins
was induced by the addition of 1 mmol/L isopropyl-1-tech). For 5 RACE, gene-specific primer-1 (GSP1, 5-GT
TCCTGCAGTATCCAAGATTTCAAG-3) and nested thio-D-galactopyranoside in the medium, and the culture
was extended for another five hours. The cells were har-gene primer-1 (NSGP1, 5-ACTGTTGTGCATCTAC
TTCAAC-3) were used. For 3 RACE, gene-specific vested by centrifugation at 5,000  g, and the pellet was
resuspended in an ice-cold binding buffer containing 5primer-2 (GSP2, 5-GACTTGGAAGATGAAAGAG
TTGTA-3) and nested gene primer-2 (NSGP2, 5-TA mmol/L imidazole/0.5 mol/L NaCl/20 mmol/L Tris-HCl,
pH 7.9 (Buffer A), and the cells were disrupted by sonica-GCAAGACAATGGAACAACTG-3) were used. The
products were subcloned into pCR II plasmid vector tion. The inclusion bodies were collected by centrifuging
the lysate at 20,000  g at 4C for 30 minutes. The pellet(InVitrogen Co.) and sequenced. At least four different
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was resuspended in a denaturing binding buffer (Buffer DTT. The sections were dehydrated in graded series
of ethanol, air-dried, coated with NTB2 photographicA  6 mol/L urea 
 Buffer B), kept on ice for one
hour and again recentrifuged. The supernatant was then emulsion (Eastman Kodak, Rochester, NY, USA), and
tissue autoradiograms prepared after two to three weeksloaded onto a nickel-charged column. The column was
washed with the Buffer B and washing buffer. The latter of exposure.
was made up of 60 mmol/L imidazole, 0.5 mol/L NaCl
Tissue expression of Rap1b by Western blot analysisand 20 mmol/L Tris-HCl, pH 7.9. The nickel-bound pro-
and immunofluorescenceteins were eluted with an elution buffer, containing 1
mol/L imidazole/0.5 mol/L NaCl/20 mmol/L Tris-HCl, 6 For Western blot analysis, tissue lysates were prepared
by homogenizing control and diabetic kidneys in ice-mol/L urea pH 7.9, (Buffer C). Protein content in each
of the eluted fraction was measured. The fractions with cold extraction buffer [10 mmol/L HEPES/1.5 mmol/L
MgCl2, 10 mmol/L KCl, 0.5 mmol/L DTT, 1 mmol/Lhigh content of proteins were pooled, dialyzed succes-
sively against 0.1 mol/L phosphate buffered saline (PBS), phenylmethylsulfonyl fluoride (PMSF), pH 7.4]. The ho-
mogenate was centrifuged at 10,000  g for 30 minutespH 7.4, and autoclaved deionized water. They were then
lyophilized and stored at 70C. The purity of the iso- at 4C, and the supernatant was saved. The protein con-
centration in the supernatant was adjusted to 2 mg/mL.lated protein was assessed by SDS-PAGE analysis.
Polyclonal antibodies were raised in rabbits by subcu- Equal amounts (20 g) of protein (control vs. diabetic)
were loaded into the gel-wells and subjected to 15%taneous injection of 1 mg of fusion protein emulsified
with incomplete Freud’s adjuvant. Four weeks after the SDS-PAGE under reducing conditions. The gel proteins
were electroblotted onto a nitrocellulose membrane. Thefirst injection, the rabbits were given three booster injec-
tions at intervals of four weeks for three months. Three membrane was immersed in a blocking solution con-
taining 5% nonfat milk in TBS-T (0.1 mol/L Tris-HCl,weeks after the last booster injection, the rabbits were
bled and antisera collected. The specificity of the anti- pH 7.5, 0.15 mol/L NaCl and 0.05% Tween-20) followed
by successive 60-minute incubations with Rap1B anti-body was determined by Western blot analysis as de-
scribed previously [24] body and goat anti-rabbit IgG conjugated with horse-
radish peroxidase at 37C. The membrane was washed
Tissue expression of Rap1b by in situ hybridization three times with TBS-T and autoradiogram developed
using enhanced chemiluminescence (ECL) Western blotTo evaluate the spatial gene expression of Rap1B in
kidney, in situ hybridization was preformed as previously kit (Amersham Co.).
For immunofluorescence microscopy, the kidneys fromdescribed [25]. Briefly, Rap1b cDNA was subcloned into
pBlueScript KS() at the EcoR I site, and it was used as both diabetic and control mice were snap-frozen in chilled
isopentane and embedded in OCT compound (Milesa template to generate [35S]-UTP-labeled sense and anti-
sense riboprobes by employing T7 and T3 RNA polymer- Laboratories). Four-micrometer thick cryostat sections
were prepared and air-dried. They were washed withase included in the Riboprobe in vitro Transcription System
kit (Promega). The riboprobes were used for hybridizing 0.01 mol/L phosphate buffered saline (PBS), pH 7.4,
followed by incubation with polyclonal anti-Rap1b anti-with the tissues sections of kidneys harvested from diabetic
and normal newborn mice kidneys. The kidneys were body for 60 minutes in a humidified chamber at 24C.
After washing with PBS, sections were incubated withimmersed in 4% phosphate buffered paraformaldehyde
for three hours at 4C. They were dehydrated in graded goat anti-rabbit IgG antibody conjugated with fluores-
cein for 30 minutes. They were washed three times withseries of ethanol and embedded in paraffin. Three-micro-
meter thick tissue sections were prepared, and mounted PBS, and then examined with an UV light microscope
equipped with epi-illumination.on glass slides coated with Vectabond (Vector Labora-
tories, Inc., Burlingame, CA, USA). The sections were
Gene expression of Rap1b in mousedeparaffinized, hydrated, treated with 0.2 N HCl, depro-
embryonic kidneysteinated by proteinase-K treatment, and acetylated with
0.1 mol/L triethanolamine and 0.25% acetic anhydride. Since Rap1b was identified in the newborn kidneys
that were subjected to hyperglycemic stress during gesta-After washing the sections with 2  SSC, they were pre-
hybridized with hybridization solution [50% formamide, tion, it led us to investigate the status of Rap1b in embry-
onic kidneys in a high glucose ambience. To study gene10% dextran sulfate, 1Denhardt’s solution, 10 mmol/L
Tris-HCl, pH 8.0, 0.3 mol/L NaCl, 1 mmol/L ethylenedi- expression in kidneys harvested at day-11 to day-13 of
gestation by Northern blot analysis, a large number ofaminetetraacetic acid (EDTA), 10 mmol/L DTT] at 50C
for three hours, followed by hybridization with [35S]UTP embryonic kidneys (500 to 1000) must be employed in
order to detect a signal of a given mRNA transcript. Tolabeled-Rap1b riboprobes at 50C for 15 hours. After hy-
bridization, the tissue sections were washed successively circumvent this difficulty, investigators have employed
quantitative competitive RT-PCR to study the mRNA ex-with 2, 1 and 0.5 SSC in the presence of 1 mmol/L
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pression in embryonic kidneys [22, 23, 25]. First, a Rap1b
competitive template was constructed by inserting sense
(5-GGAAGTCGGCTCTGACTGTAGACGACATG
GAGAAGATCTGG-3) and antisense (5-TGGAGTT
TTTCTGTTAATTTGCATGGCCACTGCCGCATC
CTC-3) primer sequences in the “mini gene construct”
prepared previously [8] (GenBank accession #U17140).
This construct has other primer sequences and is rou-
tinely used in our laboratory to assess the mRNA expres-
sion of various other genes including 	-actin. The PCR
product generated following the introduction of the above
primers was sequenced. The product was then ligated
Fig. 1. Photograph of a normal and a diabetic newborn mouse. Diabe-into pCR II plasmid vector. Using this new mutant com- tes was induced in adult pregnant mice at day-13 of gestation by the
petitive template, the expected size of the PCR products administration of streptozotocin. At day-16, mice with blood glucose
250 mg/dL were selected for continuation of their pregnancy. Thefor Rap1b and 	-actin is 317 bp and 274 bp, respectively,
newborn diabetic mouse is relatively small, markedly underweight andwhereas in wild-type cDNA, the expected size of the emaciated compared to the control.
PCR products is 520 bp and 430 bp, respectively. For
competitive RT-PCR, 50 embryonic kidneys were dis-
sected from the mouse fetuses at day-13 of gestation,
and maintained in an organ culture system for five days, ton X-100, 0.25 mmol/L DTT, 10 mmol/L benzamidine-
HCl, 10 mmol/L ε-amino--caproic acid and 2 mmol/Las detailed previously [7, 8]. Briefly, the harvested meta-
nephric explants were placed on an 0.8-m pore size phenylmethanesulfonyl fluoride) by shaking vigorously
for two hours at 4C. The extract was centrifuged atfilter, floated onto a serum-free medium, composed of
equal volumes of DME and Ham’s nutrient mixture F12, 10,000  g for 30 minutes at 4C, and the supernatant
was saved. The protein concentration was adjusted toand penicillin (100 g/mL), streptomycin (100 g/mL)
and iron poor transferrin (50 g/mL; Sigma Chemical 100g/mL. Immunoprecipitation was performed by add-
ing 10 L (10 g/mL of lyophilized IgG fraction) ofCo.). d-glucose was added and its final concentration
adjusted to 30 mmol/L. The controls included 30 mmol/L polyclonal anti-Rap1b antibody to 0.5 mL (5 to 106
dpm) of the supernatant. The supernatants containingof l-glucose or 5 mmol/L d-glucose. Total RNA was
isolated from glucose-treated explants and first strand equal amounts of radioactivity (control vs. diabetic) were
employed for immunoprecipitation. The mixture wascDNA was synthesized. For quantitative-competitive
PCR, aliquots of first strand cDNA was mixed with serial gently swirled in an orbital shaker at 4C for 15 hours.
After the addition of 80 L of protein-A Sepharose 4Bdilutions of competitive plasmid DNA and co-amplified
in the presence of either 	-actin or Rap1b primers in a (Pharmacia LKB Biotechnology, Uppsala, Sweden), the
antigen-antibody mixture was incubated for one hour atPCR mixture. The mixture consisted of 2 mmol/L MgCl2,
200 mol/L of each dNTPs and 2.5 U of Taq polymerase. 4C. The complex was then microfuged for ten seconds
and then washed three times with the extraction buffer.The DNAcDNA were first denatured by heating at
94C for two minutes, followed by one cycle of hot-start The immunoprecipitated complex was dissolved in a
sample buffer (4% SDS, 150 mmol/L Tris-HCl, pH 6.8,PCR (94C  3 min, 55C  1 min, 72C  21⁄2 min), 32
cycles of PCR (94C  1 min, 55C  1 min, 72C  21⁄2 20% glycerol, 0.1% bromophenol blue and 10% 	-mer-
captoethanol), boiled for five minutes, and subjected tomin) and extension time of ten minutes at 72C. The
amplified PCR products were analyzed by 1.5% agarose 10% SDS-PAGE. The gels were fixed in 10% acetic acid
and 10% methanol, treated with 1 mol/L salicylic acid,gel electrophoresis.
vacuum dried and autoradiograms prepared.
Expression of de novo synthesized Rap1b in mouse
embryonic kidneys
RESULTS
Approximately 60 embryonic kidneys at day-13 of ges-
Status of newborn mice following induction oftation were harvested and maintained in organ culture sys-
diabetes in uterotem containing 5 mmol/L d-glucose or 30 mmol/L d- or
l-glucose as described above. They were labeled with The diabetic newborn mice were smaller, emaciated
and substantially underweight (Fig. 1). The respective[35S]methionine (0.25 mCi/mL) for 16 hours prior to
the termination of the culture. They were rinsed with average weights of diabetic newborn versus control mice
were: 0.58  0.05 g versus 1.3  0.07 g, and their glucosethe culture media. The explants were then lysed in an
extraction buffer (50 mmol/L Tris-HCl, pH 7.5, 50 levels were: 321  29 versus 121  12 mg/dL (N 

50), respectively. About 15% of the newborn mice weremmol/L NaCl, 10 mmol/L EDTA, 0.2% Na2N3, 1% Tri-
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putative protein product of21 kD. Amino acid analysis
indicated that it has an ATP/GTP binding motif (GSGG
VGKS) near the N-terminus and 5 phosphorylation sites
distributed throughout its entire stretch (Fig. 3A). An
online homology search indicated that nucleotide and
amino acid sequences of mouse, rat and human Rap1b
are highly conserved. At the amino acid level, mouse
Rap1b had 100% and 98% identity with human and rat,
respectively. However, at the nucleotide level, it had
98% and 88% identity with human and rat, respectively.
Authentication of mouse Rap1b cDNA and
characterization of its recombinant protein
The in vitro translation, utilizing two different Rap1b
cDNAs, yielded similar size translation products with a
molecular radius (Mr) of 21 kD (Fig. 3B, lanes 2 and
3). No translated product was seen when empty vectorFig. 2. Northern blot analyses of differentially expressed genes in kid-
neys of normal (N) and diabetic (D) mice. Seven cDNA fragments by was used (Fig. 3B, lane 4). Since the products from two
suppression-subtractive hybridization were isolated, and they were used separate cDNA clones were of identical size, it indicated
as hybridization probes for Northern blot analysis of mRNAs isolated
that the isolated cDNA has a corresponding authenticfrom normal and diabetic newborn mice. Column 1: ubiquitin/60 (2.8,
1.7 and 0.8 kb transcripts). Column 2: heat shock protein70 (2.7 protein. The positive control yielding a predicated size
kb). Column 3: lactate dehydrogenase (1.7 kb). Column 4: Rap1b of the translated product of 61 kD (Fig. 3B, lane 1)
(2.3 kb). Column 5: nuclear ribonucleoprotein (1.4 kb). Column 6:
further confirmed the authenticity of the translation re-unknown (7.0 kb). Column 7: no hybridization signal. Column 8:
	-actin (2.2 kb, control). action. Further verification of the cDNA clones was ob-
tained upon generation of the fusion protein by utilizing
pET15b expression vector. The SDS/PAGE analysis re-
vealed an 23 kD protein band before (Fig. 3C, lane 2)
deformed. In some of them the kidneys were difficult to as well as after (Fig. 3C, lanes 3 and 4) purification with
visualize and were therefore excluded from the study. nickel-charged column. The excess2 kD mass presum-
ably was derived from the c-myc-(His)6-tag. The fusionIsolation of differentially expressed genes in kidneys
protein was used for generation of a rabbit polyclonalof diabetic newborn mice
antibody. The authenticity of the antibody was confirmed
By SSH-PCR, several different cDNA fragments were by Western blot analysis. A major band of the size of23
identified, and their up-regulated expression was con- kD was observed for the recombinant protein generated
firmed by Northern blot analysis (Fig. 2). The extent of from two different cDNA clones (Fig. 6A), suggesting
increased expression varied among different genes in the that the polyclonal antibody is specific for Rap1b fusion
hyperglycemic state. Nucleotide sequence analysis of these protein. Another faint band 45 kD also was observed
cDNAs indicated that five of them are known genes: (Fig. 6A). The identity of this band is unknown, but it
Ubiquitin/60S (clone 1), heat-shock protein70 (clone 2), could be a dimer of the Rap1b recombinant protein.
lactate dehydrogenase (clone 3), Rap1b (clone 4), and
nuclear ribonucleoprotein (clone 5). Two were unknown Rap1b gene expression studies in hyperglycemic state
genes (clones 6 and 7). Clone 7 did not yield any hybrid- To confirm the up-regulation of Rap1b by hyperglyce-
ization signal. Of all these genes, up-regulation in the mia, its expression was evaluated in various tissues of
mRNA expression of nuclear ribonucleoprotein (clone newborn mice and rats in which diabetes was induced
5) was minimal in the hyperglycemic state. Since some by the administration of streptozotocin at day 13 and
of the other GTP-binding proteins are known to be in- day 15 of gestation, respectively. The organs evaluated
volved in the pathogenesis of diabetes, Rap1b (clone 4) for Rap1b gene expression were kidney, liver, brain, lung
was investigated further. and heart. An increase in the expression of Rap1b was
observed in almost all the tissues of both the species,
Analysis of mouse Rap1b cDNA sequence although the increase was variable in different tissues
Using PCR amplification of mouse cDNA library cou- (Fig. 4). To establish a dose-response relationship be-
pled with SMART RACE cDNA amplification of 3- tween the degree of hyperglycemia and the blood glucose
and 5-untranslated region, a 958 bp mouse homolog of levels, mRNA expression in kidneys of newborn mice
Rap1b was isolated (Fig. 3). It had a 552 bp open reading with different blood glucose levels was determined. A
single 2.3 kb Rap1b mRNA transcript was detectableframe corresponding to 184 amino acids with a predicted
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Fig. 3. (A) Nucleotide and deduced amino
acid sequence of mouse Rap1b. A 552 bp open
reading frame flanked by 5- and 3-untrans-
lated regions is shown. The ATP/GTP-binding
site motif is indicated by bold underline. Cir-
cles indicate amino acid residues of five phos-
phorylation sites. The sequence of the anti-
sense primer is indicated by a dotted long
arrow, and it was used for the amplification
of cDNA library. The nucleotide sequences
of gene specific primer1 (GSP1) and GSP2
are indicated by left- and right-handed long
arrows, respectively. They were used for am-
plification of respective 5- and 3-flanking re-
gions of Rap1b. The threonine at position 61,
needed for its intrinsic GTPase activity, is con-
served in mice, rat and human. Also, the serine
residue at position 179, essential for phosphor-
ylation, is conserved in all the three species.
(B) SDS-PAGE autoradiogram of in vitro
translation products. The 21 kD band in
lanes 2 and 3 represent translated products of
2 different Rap1b cDNAs cloned into pCR
2.1 plasmid vector. Lane 1 with61 kD repre-
sents a positive control. Lane 4 represents in
vitro translation of pCR 2.1 vector without
Rap1b cDNA insert. (C ) SDS-PAGE analysis
of recombinant (His)6-tag-Rap1b protein,
generated by using pET15b bacterial expres-
sion system. An 23 kD band is seen after
IPTG induction in whole E. coli lysate (lane
2). Lanes 3 and 4 represent the purified recom-
binant protein from two different Rap1b
cDNA clones that were used for transforma-
tion of the E. coli. Lane 1 represents the bacte-
rial lysate where empty pET15b plasmid vec-
tor was used for transformation.
in the kidney of newborn mice with blood glucose level tended into the outer medullary and cortical collecting
tubules (Fig. 5E). No expression was seen in the glomer-125 mg/dL (Fig. 5A). The Rap1b mRNA expression
increased proportionately to the blood glucose levels. uli of either control or diabetic newborn mice kidneys.
Densitometric analyses revealed more than tenfold in-
Rap1b protein expression in hyperglycemic statecrease in the Rap1b expression in kidneys of mice with a
blood glucose level400 mg/dL, suggesting a convincing The protein expression studies confirmed the observa-
tions made by Northern blot analysis and in situ hybrid-dose-response relationship. Next, the spatio-temporal
expression of Rap1b was evaluated by in situ hybridiza- ization. Western blot analysis of the homogenate of nor-
moglycemic mice newborn kidneys revealed an 21 kDtion in the newborn kidneys. In control kidneys, the
hybridization signal was confined to the inner medullary band (Fig. 6B). The intensity of the band was notably
increased in kidney samples of diabetic mice that con-collecting tubules (Fig. 5D), while in diabetic newborn
mice kidneys the expression notably increased and ex- tained comparable amounts of total protein loaded in
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Fig. 4. Northern blot analysis depicting Rap1b mRNA expression in various tissues collected from control (C) and newborn diabetic (D) mice
and rats (upper panel). A variable increase in its expression is observed in all the tissues. The 	-actin expression is similar in control and diabetic
animals (middle panel). The lower panel indicates the quality and equal loading of total RNA in various lanes.
SDS-PAGE (Fig. 6B). Using immunofluorescence mi- in high glucose ambience. For Rab1b control, a ratio
of one was obtained at dilutions 106 to 107 of thecroscopy, some of the inner medullary collecting tubules
and a very few in the cortex revealed immunoreactivity competitive plasmid DNA (Fig. 7C), while in embryonic
kidneys exposed to 30 mmol/L glucose, the ratio of onewith anti-Rap1b antibody (Fig. 6 C, D). While in diabetic
newborn mice, the extent of immunoreactivity with the was obtained at 104 to 105 dilutions of the competitive
DNA (Fig. 7D), suggesting a 10- to 100-fold increase inkidney tubules was increased (Fig. 6 E, F). Also, there
was a noticeable increase in the immunoreactive collect- the Rap1b mRNA expression in high glucose ambience.
The up-regulated mRNA expression gave impetus toing tubules, both in the medulla and the cortex. The spatial
expression of Rap1b co-localized with aquaporin-2 (not investigate the Rap1b protein expression during embry-
onic life. This was accomplished by immunoprecipitationshown), suggesting that Rap1b is expressed in the collect-
ing tubules. The findings included in Figures 6 C–F and of the radiolabeled proteins of embryonic explants sub-
5 D and E indicate that Rap1b gene and protein spatial jected to normal and high glucose conditions. The SDS-
expressions are similar in the kidney under basal condi- PAGE autoradiograms of the immunoprecipitated meta-
tions and in hyperglycemic states. nephric proteins revealed a major band of 21 kD (Fig.
7E). The intensity of the band increased in the immuno-
Expression of Rap1b in embryonic kidneys in high precipitated proteins isolated from embryonic explants
glucose ambiance exposed to 30 mmol/L glucose (Fig. 7E), thereby sug-
In order to examine Rap1b mRNA expression during gesting an up-regulated expression of de novo synthe-
embryonic life and in high glucose ambience, organ cul- sized Rap1b.
ture experiments were performed. Metanephroi were
exposed 30 mmol/L d-glucose for four days along with
DISCUSSIONappropriate controls, and then processed for competitive
There are a number of different methods that oneRT-PCR analysis. A linearity in the ratios of PCR prod-
can employ to study the differential gene regulation inucts of Rap1b cDNA to minigene plasmid DNA could
various biological and pathobiological processes. Thebe maintained when plotted against 101 to 108 serial
most elegant method that is currently in use includes thelogarithmic dilutions of the competitive plasmid DNA.
cDNA-array technique described a few years ago byWithin this range of serial dilutions, the bands of embry-
Brown and colleagues [26], and it has been the subjectonic kidney Rap1b cDNA and plasmid DNA PCR prod-
of several recent reviews [27–29]. By this method, a largeucts were discernible for densitometric analysis to obtain
number of genes are screened and isolated, and manya ratio (Fig. 7). For 	-actin control, a ratio of one was
redundant genes (false-positive) may be identified. How-obtained at dilutions 105 to 106 of the competitive
ever, the cDNA array method is somewhat expensiveplasmid DNA (Fig. 7A). This ratio was similar in embry-
and no new genes can be identified by this technique.onic kidneys exposed to 30 mmol/L glucose (Fig. 7B),
indicating no change in the 	-actin mRNA expression Therefore, most of the laboratories rely on the use of
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lated in a hyperglycemic environment. In the present
study, the kidney was further stressed by subjecting it
to a hyperglycemic environment during embryonic de-
velopment. As a consequence, many new genes that are
differentially regulated were identified (Fig. 2), although
some of them, for example, ubiquitin, ribosomal protein
L-40 and nuclear ribonucleoprotein, had been previously
identified in our laboratory [30]. One of the genes that
exhibited differential up-regulation in hyperglycemia
was Rap1b, a small GTP binding protein.
The Rap1b is a Ras-related (Ras-proximate) GTP-
binding protein that belongs to a superfamily consisting
of many members, including Ras, Rho/Rac/Cdc42, Rad,
Rab, Ral, Ran and Sar1/Arf, and they regulate cell prolif-
eration, differentiation, intracellular vesicular traffick-
ing, cytoskeletal rearrangement, cell cycle events and
glucose transport [39]. These are small molecular weight
proteins that behave as GTPase and cycle between GTP-
bound (active) and GDP-bound states (inactive) associ-
ated with a conformational change. The active state is
induced by guanine nucleotide exchange factors (GEFs)
with the dissociation of GDP and allowing the associa-
tion of the more abundant intracellular GTP. To achieve
a state of inactivity, the GTP is hydrolyzed to GDP by the
intrinsic GTPase activity in combination with GTPase-
activating proteins (GAPs). Rap1 is ubiquitously ex-
pressed and is endowed with properties that are antago-
nistic to Ras signaling transductional effects. Originally,
the Rap1 was identified in a screen of cDNAs that revert
the morphology of K-Ras-transformed cells [40]. It also
has been shown that insulin treatment results in the de-
repression of Rap1 inhibitory function on the Raf1 ki-Fig. 5. In normoglycemic animals with blood glucose level of 125 mg/
nase concomitant with Ras activation and stimulationdL, a single mRNA transcript of the size of 2.3 kb is shown (A-C ).
The Rap1b mRNA expression in the kidneys rises proportionally to of the downstream Raf1/MEK/ERK cascade [41]. It is
blood glucose levels of newborn diabetic mice. The 	-actin expression conceivable that Rap1 interferes in Ras signaling by trap-is unchanged (B). (C) The quality and equal loading of total RNA in
ping Raf1 in an inactive complex. One of the criticalvarious lanes. (D and E) In situ tissue autoradiograms depict Rap1b
mRNA expression in kidneys of control (D) and newborn diabetic (E) amino acid residues that dictates its differing functions
mice. In the control, the Rap1b mRNA expression is confined to the from Ras is the glutamine at position 61 that is substi-inner medullary collecting tubules. In diabetic mice, the expression is
tuted to threonine in Rap1 (Fig. 3), and as a result it hasaccentuated and has extended into outer medullary collecting tubules.
No expression is observed in the glomeruli. a tenfold lower intrinsic GTPase activity than Ras. Rap1
can be activated by wide variety of stimuli, and they
include epidermal, platelet-derived (PDGF) and nerve
growth factors and phospholipase C [42, 43]. In addition,other subtraction methods, such as, representational dif-
there are three distinct second messengers—calcium, di-ference analysis (RDA) of cDNA and suppression sub-
acylglycerol (DAG) and adenosine 3, 5-cyclic mono-tractive hybridization (SSH)-PCR to study the differen-
phosphate (cAMP)—that also can induce the activationtial gene regulation [18, 19]. This technique of subtractive
of Rap1 [42, 43].hybridization has been employed by several investigators
The next question that needs to be addressed is theto study the gene regulation in various tissues in diabetes
mechanism(s) by which Rap1b or other Ras-related GTPmellitus and in cells exposed to high glucose ambience
binding proteins are activated or up-regulated in the[17, 24, 30–38]. Using SSH-PCR, previously our labora-
hyperglycemic state. In this regard, there is a substantialtory described some of the novel genes in kidneys of
amount of information indicating the relevance of Gthree-week-old diabetic mice [24, 30]. During this time
proteins in diabetic complications [44–46]. In addition,frame of post-natal life, the kidneys are still developing
a number of small GTP-binding proteins have been im-and can be readily stressed, which yields an optimum
chance to identify the genes that are differentially regu- plicated in the pathogenesis of hyperglycemia-induced
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Fig. 6. (A) Western blot analysis of Rap1B fusion protein. A band of 23 kD size protein is detected when hybridized with anti-Rap1B antibody.
Two different Rap1b recombinant fusion proteins, generated from separate cDNA clones, yielded identical size protein products (lanes 1 and 2).
Another faint band of 45 kD may be the dimer of Rap1b protein. (B) Rap1B protein expression in kidneys of control and diabetic mouse by
Western blot analysis. A 21 kD size band is observed in the kidney of control newborn mice. The band intensity notably increased in the kidney
of diabetic mice. (C–F:) Low (C and D) and high (E and F) magnification immunofluorescence photomicrographs of renal tissue sections from
normoglycemic (C and D) in newborn diabetic (E and F) mice stained with anti-Rap1b antibody. In normal mouse kidney, a low level of anti-
Rap1B immunoreactivity is observed in the renal inner medullary collecting tubules (C and D). In diabetic mouse kidney, the Rap1B expression
signal is intensified and extended into the outer medullary and cortical collecting tubules (E and F).
Fig. 7. Competitive RT-PCR analysis of
-actin (A and B) and Rap1b (C and D)
cDNAs prepared from embryonic renal ex-
plants treated with 5 mmol/L D-glucose or 30
mmol/L L-glucose (A and C) and 30 mmol/L
D-glucose (B and D). For 	-actin, no signifi-
cant differences in the amplification of the
wild-type cDNA versus competitive plasmid
DNA is observed since a ratio of 1 is obtained
in both the low and high glucose ambience at
log dilutions 105 to 106 of the competitive
plasmid DNA (A and B). For Rap1b, an in-
crease in the amplification of wild-type cDNA
versus competitive plasmid DNA is observed
since a ratio of 1 has shifted from 106 to 107
(control) to 104 to 105 (30 mmol/L glucose)
log dilutions of the competitive DNA. This
indicates 10- to 100-fold increase in Rap1B
mRNA expression in the renal explants sub-
jected to high glucose ambience. (E) SDS-
PAGE autoradiogram of the de novo synthe-
sized Rap1B. The control and 30 mmol/L glu-
cose treated metanephroi were labeled with
[35S]methionine and the radiolabeled proteins
were extracted, immunoprecipitated with anti
Rap1B antibody, subjected SDS-PAGE, and
autoradiograms developed. A major band of
21 kD is seen and its intensity notably in-
creased in embryonic explants treated with 30
mmol/L glucose.
complications. They include Rad (Ras associated with relevant to the present discussion include protein kinase
A and C [51–53], calcium [54], diacylglycerol [52, 53, 55],diabetes) [47], Gem (GTP-binding protein induced by
mitogens) [48], Rho [49] and Gsalpha/Gq/11alpha [50]. PDGF [56], nerve growth factor [57] and cAMP [58, 59].
These molecules, besides being implicated in the patho-As to the mechanisms involved, the role of molecules
in the pathogenesis of diabetic complications that are genesis of diabetic complications, also affect, directly or
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indirectly, the activation of small GTP-binding proteins, To address this issue, organ culture experiments were per-
formed, where metanephroi, harvested at day-13 of ges-including Rap1b [42, 43]. This in turn would modulate
the activity of various mitogen activated protein (MAP) tation were exposed to a high glucose ambience (Fig. 7).
The fact that the competitive RT-PCR analysis and im-kinases and transcription factors and gene expression of
various extracellular matrix (ECM) proteins, such as fi- munoprecipitation experiments indicated a 10- to 100-
fold increased expression of Rap1b suggests that thebronectin [60, 61]. The role of small GTP-binding proteins
in the regulation of fibronectin expression seems to be me- changes observed in vivo are indeed related to a hyper-
glycemic stimulus response rather than to toxicity ofdiated via transforming growth factor-	 (TGF-	) [62, 63],
which is a powerful cytokine that plays a central role in some of the circulating metabolites of glucose. Lastly,
information about 5-upstream region of mouse Rap1bthe pathogenesis of diabetic nephropathy [64, 65]. An-
other intriguing possibility for the hyperglycemia-induced is not available in the literature. Such information, per-
taining to the promoter analysis of Rap1b, could alsoup-regulation of Rap1b may be the insulin deficiency that
occurred due to the administration of streptozotocin. Nor- shed some light as to the mechanism(s) involved in its
up-regulation in response to a hyperglycemic stimulusmally, Rap1 and Ras are in counter-equilibrium with
one another inside the cell, that is, when one is in an or stress. For instance, one may find consensus sequences
for binding of various transcription factors or glucoseactive state the other one would be in an inactive state.
This is best exemplified by the action of insulin, which response elements (GRE), the latter case would suggest
a direct stimulus for the up-regulation of Rap1b by glu-upon binding to the receptor tyrosine kinase leads to
the inactivation of Rap1 by its dissociation from Raf1, cose. These studies would certainly enhance our under-
standing of the signal transductional events that do occurand Raf1 in turn gets associated with GTP-bound Ras
with subsequent Raf1-dependent phosphorylation and as a response to a given hyperglycemic stimulus, and
they should be the subjects of future investigations.activation of ERK and downstream events [41]. Con-
versely, the deficiency of insulin would be expected to In summary, the data of this investigation suggest that
there is an increased expression of Rap1b in hyperglyce-result in the activation of Rap1b. Therefore, insulino-
penia may be one of the factors responsible for the up- mia, and this small molecular weight GTP-binding pro-
tein is another molecule that, most likely, is relevant toregulation of Rap1b as observed here.
The mechanism(s) listed above would be applicable the pathogenesis of diabetic complications. It is antici-
pated that this simple basic observation should give im-in a wide variety of tissues because of the ubiquitous
distribution of the Rap1b. The examination of various petus to further study the role of GTP-binding proteins
in the pathobiology of diabetes mellitus and to delineatetissues revealed that the up-regulation of Rap1b was not
restricted to the kidney, but many other tissues also the mechanism(s) involved in the up-regulation or activa-
tion of Rap1b in the hyperglycemic environment.exhibited its increased mRNA expression, although to
varying degrees (Fig. 4). The fact that the increased ex-
pression was proportional to the blood glucose levels in ACKNOWLEDGMENTS
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